Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jos Prickaerts

Showing results (61-70 of 170) with videos related to

Pageof 17
Sort By:
Synapse (New York, N.Y.)|February 15, 2020
Phosphodiesterase inhibitors roflumilast and vardenafil prevent sleep deprivation-induced deficits in spatial pattern separationPim R A Heckman, Femke Roig Kuhn, Frank Raven, et al.
Pharmacology, Biochemistry, and Behavior|March 1, 2006
Functional investigations into the role of dopamine and serotonin in partial bilateral striatal 6-hydroxydopamine lesioned ratsBart Scholtissen, Ronald Deumens, Albert F G Leentjens, et al.
Neuropsychobiology|April 28, 2012
Increase in serum brain-derived neurotrophic factor in met allele carriers of the BDNF Val66Met polymorphism is specific to malesBoudewijn A A Bus, Alejandro Arias-Vasquez, Barbara Franke, et al.
Neuropharmacology|June 23, 2018
Roflumilast promotes memory recovery and attenuates white matter injury in aged rats subjected to chronic cerebral hypoperfusionAmanda Santiago, Lígia Mendes Soares, Melissa Schepers, et al.
The European Journal of Neuroscience|November 5, 2016
The phosphodiesterase type 2 inhibitor BAY 60-7550 reverses functional impairments induced by brain ischemia by decreasing hippocampal neurodegeneration and enhancing hippocampal neuronal plasticityLigia Mendes Soares, Erika Meyer, Humberto Milani, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 31, 2009
Stress-mediated decreases in brain-derived neurotrophic factor as potential confounding factor for acute tryptophan depletion-induced neurochemical effectsEva L van Donkelaar, Daniël L A van den Hove, Arjan Blokland, et al.
The International Journal of Neuropsychopharmacology|July 30, 2010
Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?Gunter Kenis, Jos Prickaerts, Jim van Os, et al.
Journal of Psychopharmacology (Oxford, England)|November 7, 2019
Pro-cognitive effect of upregulating cyclic guanosine monophosphate signalling during memory acquisition or early consolidation is mediated by increased AMPA receptor traffickingElentina K Argyrousi, Pim Ra Heckman, Britt Tj van Hagen, et al.
Cells|October 17, 2019
From OPC to Oligodendrocyte: An Epigenetic JourneyAssia Tiane, Melissa Schepers, Ben Rombaut, et al.
Physiology & Behavior|March 3, 2010
Effects of chronic stress: a comparison between tethered and loose sowsF Josef van der Staay, Teun Schuurman, Marcel Hulst, et al.
Pageof 17

Showing results (61-70 of 170) with videos related to

Sort By:
Pageof 17
Synapse (New York, N.Y.)|February 15, 2020
Phosphodiesterase inhibitors roflumilast and vardenafil prevent sleep deprivation-induced deficits in spatial pattern separationPim R A Heckman, Femke Roig Kuhn, Frank Raven, et al.
Pharmacology, Biochemistry, and Behavior|March 1, 2006
Functional investigations into the role of dopamine and serotonin in partial bilateral striatal 6-hydroxydopamine lesioned ratsBart Scholtissen, Ronald Deumens, Albert F G Leentjens, et al.
Neuropsychobiology|April 28, 2012
Increase in serum brain-derived neurotrophic factor in met allele carriers of the BDNF Val66Met polymorphism is specific to malesBoudewijn A A Bus, Alejandro Arias-Vasquez, Barbara Franke, et al.
Neuropharmacology|June 23, 2018
Roflumilast promotes memory recovery and attenuates white matter injury in aged rats subjected to chronic cerebral hypoperfusionAmanda Santiago, Lígia Mendes Soares, Melissa Schepers, et al.
The European Journal of Neuroscience|November 5, 2016
The phosphodiesterase type 2 inhibitor BAY 60-7550 reverses functional impairments induced by brain ischemia by decreasing hippocampal neurodegeneration and enhancing hippocampal neuronal plasticityLigia Mendes Soares, Erika Meyer, Humberto Milani, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 31, 2009
Stress-mediated decreases in brain-derived neurotrophic factor as potential confounding factor for acute tryptophan depletion-induced neurochemical effectsEva L van Donkelaar, Daniël L A van den Hove, Arjan Blokland, et al.
The International Journal of Neuropsychopharmacology|July 30, 2010
Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?Gunter Kenis, Jos Prickaerts, Jim van Os, et al.
Journal of Psychopharmacology (Oxford, England)|November 7, 2019
Pro-cognitive effect of upregulating cyclic guanosine monophosphate signalling during memory acquisition or early consolidation is mediated by increased AMPA receptor traffickingElentina K Argyrousi, Pim Ra Heckman, Britt Tj van Hagen, et al.
Cells|October 17, 2019
From OPC to Oligodendrocyte: An Epigenetic JourneyAssia Tiane, Melissa Schepers, Ben Rombaut, et al.
Physiology & Behavior|March 3, 2010
Effects of chronic stress: a comparison between tethered and loose sowsF Josef van der Staay, Teun Schuurman, Marcel Hulst, et al.
Pageof 17